Comparative effects of 1.25 vs. 1.5mmol/L dialysate calcium concentrations on blood pressure variability during

Daqing Hong1,2,3, Changlian Li4,5, Yun Zhang6

  • 1Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Frontiers in Medicine
|March 30, 2026
PubMed

Insights

Lowering dialysate calcium concentration during hemodialysis significantly reduces blood pressure variability (BPV). This suggests a strategy to improve hemodynamic stability and patient outcomes in dialysis patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Clinical Chemistry

Background:

  • Blood pressure fluctuations in hemodialysis patients are linked to adverse cardiovascular events.
  • The optimal dialysate calcium concentration for managing blood pressure variability (BPV) is debated.

Purpose of the Study:

  • To compare the effects of two dialysate calcium concentrations (1.25 mmol/L vs. 1.5 mmol/L) on intradialytic blood pressure variability.
  • To identify the optimal dialysate calcium concentration for minimizing BPV in hemodialysis patients.

Main Methods:

  • Retrospective cohort study analyzing 2,061 hemodialysis sessions from 711 patients.
  • Patients were divided into two groups based on dialysate calcium: 1.25 mmol/L (n=473) and 1.5 mmol/L (n=238).
  • Blood pressure variability was defined as the difference between maximum and minimum blood pressure during dialysis.

Main Results:

  • The 1.25 mmol/L group showed significantly lower systolic (SBPV), diastolic (DBPV), and mean arterial pressure variability (MAPV) compared to the 1.5 mmol/L group (p < 0.001 for all).
  • Smaller serum total calcium changes occurred in the 1.25 mmol/L group, correlating positively with SBPV and MAPV.
  • Higher dialysate calcium (1.5 mmol/L) was independently associated with greater BPV after adjusting for confounders.

Conclusions:

  • Lowering dialysate calcium concentration to 1.25 mmol/L may enhance hemodynamic stability during hemodialysis.
  • Minimizing calcium flux through lower dialysate calcium concentrations could reduce blood pressure fluctuations.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.8K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.5K
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
312
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.7K
Ionic Strength: Effects on Chemical Equilibria01:19

Ionic Strength: Effects on Chemical Equilibria

The addition of an inert ionic compound increases the solubility of a sparingly soluble salt. For example, adding potassium nitrate to a saturated solution of calcium sulfate significantly enhances the solubility of calcium sulfate. Le Châtelier's principle cannot predict this shift in the equilibrium. Instead, this could be explained in terms of changes in the effective concentration of the ions in solution in the presence of added inert salt.
In this solution, the primary...
3.1K